Vancouver’s Canexia Health is merging with Montréal’s Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real world data. Canexia is an oncology innovator that streamlines complex cancer genomic information which allows oncologists to identify optimal treatment selection and patient monitoring. The merger includes a $20 million funding round that included BDC Capital’s […]
Canexia Health
BC Tech Announces Winners of 2021 Technology Impact Awards
Now in their 28th year, the Technology Impact Awards (TIAs) have never had more reasons to celebrate than they did last night at Science World. The sold-out TIAs Gala returned to an in-person format while also broadcasting the event live to the tech community. “It was wonderful to come together as a community and experience […]
BC Tech Unveils Finalists For 2021 Technology Impact Awards
The BC Tech Association has announced the finalists for the 2021 Technology Impact Awards (TIAs). “Throughout the COVID-19 crisis the province’s tech sector pulled together to support our communities, help small business to adopt technology, provide reskilling programs and put workers displaced by Covid into new jobs in the tech sector,” said Jill Tipping, BC […]
Canadian Program to Deploy Cancer Testing During COVID-19 Reaches Key Milestones
COVID-19 has delayed at least 100,000 surgeries in Canada, including up to 30 percent of cancer-related surgeries such as tissue biopsies. Currently, surgery backlogs are estimated to be 1-2 years across the country. Circulating tumor DNA (ctDNA) testing has been found to be an effective alternative to some surgical tissue biopsies to guide cancer targeted […]
New Funding To Accelerate Canexia Health’s Precision Oncology Roadmap
Canexia Health has raised a new financing round from PacBridge Capital Partners to support the company’s long-term global growth and accelerate its roadmap to make cancer testing for treatment selection and monitoring accessible to all cancer patients. The amount of the funding round was not disclosed. Formerly known as Contextual Genomics, Canexia makes high-quality cancer […]
Canexia Health To Offer Cancer Testing and Treatment During COVID-19
Cancer patients have an estimated two-fold increased risk of contracting COVID-19 and a three-fold risk of dying compared to the general population. Since early March, COVID-19 has delayed or postponed at least 100,000 surgeries in Canada including cancer tissue biopsies. A comprehensive approach is required to address the needs of this high-risk group to limit […]